Cannara Biotech Inc. LOVFF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.65% | -47.76% | -55.58% | -42.51% | 98.41% |
| Total Depreciation and Amortization | 31.82% | -16.60% | 0.27% | 25.91% | -18.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -82.37% | -- |
| Total Other Non-Cash Items | -17.46% | 75.58% | 227.26% | 129.27% | 224.74% |
| Change in Net Operating Assets | -137.16% | 68.82% | -148.45% | -4,387.82% | 173.72% |
| Cash from Operations | -58.17% | 220.40% | 34.45% | -11.43% | 211.50% |
| Capital Expenditure | -104.28% | -129.34% | -273.85% | -196.78% | 30.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 1,115.48% | -99.27% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,056.33% | 27.63% | 45.73% | 82.18% | 36.27% |
| Cash from Investing | -237.26% | -124.15% | -282.69% | -184.55% | -119.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.19% | -305.79% | -9.19% | -14.51% | 44.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.96% | 81.96% | 35.82% | 4.48% | -217.13% |
| Cash from Financing | 153.61% | 550.25% | -20.33% | -2.16% | -123.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.03% | 207.73% | -41.62% | -104.11% | 288.39% |